Search results
Showing 586 to 600 of 667 results for kidney or kidneys or renal
This guidance has been updated and replaced by NICE guideline NG203.
Ultrasound‑enhanced, catheter‑directed thrombolysis for pulmonary embolism (IPG524)
Evidence-based recommendations on ultrasound enhanced catheter-directed thrombolysis for pulmonary embolism. This involves using ultrasound waves and a drug to break up the clot.
Evidence-based recommendations on colistimethate sodium (Colobreathe) and tobramycin (TOBI Podhaler) dry powders for inhalation for treating pseudomonas lung infection in cystic fibrosis in people of 6 years and over.
Evidence-based recommendations on osimertinib (Tagrisso) for adjuvant treatment of stage 1b to 3a non-small-cell lung cancer after complete tumour resection in adults.
Show all sections
ClearWay RX for drug delivery to coronary artery thrombotic lesions (MIB55)
NICE has developed a medtech innovation briefing (MIB) on ClearWay RX for drug delivery to coronary artery thrombotic lesions
Topical antimicrobial dressings for locally infected leg ulcers: late-stage assessment (HTE27)
Late stage assessment (LSA) guidance on topical antimicrobial dressings for locally infected leg ulcers....
View recommendations for HTE27Show all sections
Evidence-based recommendations on automated ankle brachial pressure index measurement devices to detect peripheral arterial disease in people with leg ulcers.
This guidance has been updated and replaced by NICE technology appraisal guidance 1075.
This guidance has been updated and replaced by NICE guideline CG182.
crystalloid use has become more common after reports of increased risks of acute kidney injury, coagulopathy and mortality with colloid....
Evidence-based recommendations on sacubitril valsartan (Entresto) for treating symptomatic chronic heart failure with reduced ejection fraction.
NICE has developed a medtech innovation briefing (MIB) on microINR for anticoagulation therapy .
Lenalidomide plus dexamethasone for previously untreated multiple myeloma (TA587)
Evidence-based recommendations on lenalidomide (Revlimid) plus dexamethasone for previously untreated multiple myeloma in adults.
Acute kidney injury: prevention, detection and management (CG169)
This guidance has been updated and replaced by NICE guideline NG148.
Chronic kidney disease (stage 5): peritoneal dialysis (CG125)
This guidance has been updated and replaced by NICE guideline NG107.